04:33 PM EDT, 08/26/2024 (MT Newswires) -- Trinity Biotech ( TRIB ) said Monday it received substantial additional orders for TrinScreen HIV and is increasing its 2024 sales revenue outlook for the product to $10 million from $8 million.
Shares of the company surged over 39% in recent after-hours activity.
Price: 2.8300, Change: +0.80, Percent Change: +39.41